Commitments and Contingencies (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Dec. 30, 2020
Product Liability Contingency [Line Items]
Milestone payment, description	milestones of $1 million for each additional final marketing approval that we obtain.
Payment of due amount	$ 0	$ 0
Aldoxorubicin [Member]
Product Liability Contingency [Line Items]
Amount of milestone payment payable	7,500,000
Arimoclomol [Member]
Product Liability Contingency [Line Items]
Amount of milestone payment payable	3,650,000
Innovivel [Member]
Product Liability Contingency [Line Items]
Future earnout merger consideration	$ 18,300,000